Early Events in M-CSF Receptor Signaling

References

• Alessi D. R., James S. R., Downes C. P., Holmes A. B., Gaffney P. R. J., Reese C. B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein Bα. Curr. Biol. 1997; 7: 261–269
   PubMed Web of Science ®Google Scholar
• Alonso G., Koegl M., Mazurenko N., Courtneidge S. A. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors. J. Biol. Chem. 1995; 270: 9840–9848
   PubMed Web of Science ®Google Scholar
• Bignon J. S., Siminovitch K. A. Identification of PTP1C mutation as a genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 1994; 73: 168–179
   PubMedGoogle Scholar
• Bishayee A., Beguinot L., Bishayee S. Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor C-terminal tail. Mol. Biol. Cell 1999; 10: 525–536
   PubMed Web of Science ®Google Scholar
• Bourette R. P., Arnaud S., Myles G. M., Blanchet J.-P., Rohrschneider L. R., Mouchiroud G. Mona, a novel hematopoietic-specific adapter interacting with the macrophage-colony-stimulating factor receptor, is implicated in monocyte/macrophage development. EMBO J. 1998; 17: 7273–7281
   PubMed Web of Science ®Google Scholar
• Bourette R. P., Myles G. M., Carlberg K., Rohrschneider L. R. Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells. Cell Growth Diff. 1995; 6: 631–645
   PubMedGoogle Scholar
• Bourette R. P., Myles G. M., Choi J.-L., Rohrschneider L. R. Sequential activation of phosphatidylinositol 3-kinase and phospholipase C-γ2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J. 1997; 16: 5880–5893
   PubMed Web of Science ®Google Scholar
• Burshtyn D. N., Long E. O. Regulation through inhibitory receptors: lessons from the natural killer cells. TIBS 1997; 7: 473–484
   Google Scholar
• Carlberg K., Rohrschneider L. R. Characterization of a novel tyrosine phosphorylated 100 kDa protein that binds to SHP-2 and phosphatidylinositol 3′-kinase in hematopoietic cells. J. Biol. Chem. 1997; 272: 15943–15950
   PubMed Web of Science ®Google Scholar
• Chaturvedi P., Reddy M. V. R., Reddy E. P. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene 1998; 16: 1749–1758
   PubMed Web of Science ®Google Scholar
• Chen H. E., Chang S., Trub T., Neel B. G. Regulation of colony-stimulating factor 1 receptor signaling in murine macrophages by the SH2-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 1995; 16: 3685–3697
   Web of Science ®Google Scholar
• Cirri P., Chiarugi P., Marra F., Raugei G., Camici G., Manao G., Ramponi G. c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem. Biophys. Res. Comm. 1997; 239: 493–497
   PubMed Web of Science ®Google Scholar
• Courtneidge S. A., Dhand R., Pilat D., Twamley G. M., Waterfield M. D., Roussel M. F. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J. 1993; 12: 943–950
   PubMed Web of Science ®Google Scholar
• Damen J. E., Liu L., Rosten P., Humphries R. K., Jefferson A. B., Majerus P. W., Krystal G. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Nat. Acad. Sci. USA 1996; 93: 1689
   PubMed Web of Science ®Google Scholar
• De Sepulveda P., Okkenhaug K., La Rose J., Hawley R. G., Dubreuil P., Rottapel R. Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation. EMBO J. 1999; 18: 904–915
   PubMed Web of Science ®Google Scholar
• del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687–689
   PubMed Web of Science ®Google Scholar
• Dubreuil P., Torres H., Courcoul M. A., Birg F., Mannoni P. C-Fms expression is a molecular marker of human acute myeloid leukemias. Blood 1988; 72: 1081–1085
   PubMed Web of Science ®Google Scholar
• Enver T., Heyworth C. M., Dexter T. M. Do stem cells play dice?. Blood 1998; 92: 348–351
   PubMed Web of Science ®Google Scholar
• Franke T. F., Kaplan D. R., Cantley L. C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997; 275: 665–668
   PubMed Web of Science ®Google Scholar
• Geier S. J., Algate P. A., Carlberg K., Flowers D., Friedman C., Trask B., Rohrschneider L. R. The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 1997; 89: 1876–1885
   PubMed Web of Science ®Google Scholar
• Gu H., Pratt J. C., Burakoff S. J., Neel B. G. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Molecular Cell 1998; 2: 729–740
   PubMed Web of Science ®Google Scholar
• Gupta N., Scharenberg A. M., Fruman D. A., Cantley L. C., Kinet J.-P., Long E. O. The SH2 domain-containing inositol 5′-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcγRIIb1-mediated inhibition of B cell receptor signaling. J. Biol. Chem. 1999; 274: 7489–7494
   PubMed Web of Science ®Google Scholar
• Hamilton J. A. CSF-1 signal transduction. J. Leuk. Biol. 1997; 62: 145–155
   PubMed Web of Science ®Google Scholar
• Hanks S. K., Quinn A. M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Meth. Enzymol. 1991; 200: 38–62
   PubMed Web of Science ®Google Scholar
• Helgason C. D., Damen J. E., Rosten P., Grewal R., Sorenson P., Chappel S. M., Borowski A., Jirik F., Krystal G., Humphries R. K. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998; 12: 1610–1620
   PubMed Web of Science ®Google Scholar
• Hubbard S. R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 1997; 16: 5572–5581
   PubMed Web of Science ®Google Scholar
• Hubbard S. R., Wei L., Ellis L., Hendrickson W. A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994; 372: 746–754
   PubMed Web of Science ®Google Scholar
• Joos H., Trouliaris S., Helftenbein G., Niemann H., Tamura T. Tyrosine phosphorylation of the juxta-membrane domain of the v-Fms oncogene product is required for its association with a 55-kDa protein. J. Biol. Chem. 1996; 271: 24476–24481
   PubMed Web of Science ®Google Scholar
• Kacinski B. M. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev. 1997; 46: 71–74
   PubMed Web of Science ®Google Scholar
• Keating M. T., Escobedo J. A., Williams L. T. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation. J. Biol. Chem. 1988; 263: 12805–12808
   PubMed Web of Science ®Google Scholar
• Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997; 386: 181–186
   PubMed Web of Science ®Google Scholar
• Lamkin T. D., Walk S. F., Liu L., Damen J. E., Krystal G., Ravichandran K. S. Shc interaction with Src homology 2 domain containing isositol phosphatase (SHIP) in vivo requires the Shc-Phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J. Biol. Chem. 1997; 272: 10396–10401
   PubMed Web of Science ®Google Scholar
• Le Good J. A., Ziegler W. H., Parekh D. B., Alessi D. R., Cohen P., Parker P. J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998; 281: 2042–2045
   PubMed Web of Science ®Google Scholar
• Lewis T. S., Shapiro P. S., Ahn N. G. Signal transduction through MAP kinase cascades. Adv. Canc. Res. 1998; 74: 49–139
   PubMed Web of Science ®Google Scholar
• Lioubin M. N., Algate P. A., Tsai S., Carlberg K., Aebersold R., Rohrschneider L. R. p 150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 1996; 10: 1084–1095
   PubMed Web of Science ®Google Scholar
• Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 1998; 95: 10626–10631
   PubMed Web of Science ®Google Scholar
• Liu L., Damen J. E., Ware M. D., Krystal G. Interleuken-3 induces the association of the inositol 5-phosphatase SHIP and SHP2. J. Biol. Chem. 1997; 272: 10998–11001
   PubMed Web of Science ®Google Scholar
• Lucas D. M., Rohrschneider L. R. A novel spliced form of SH2-containing inositol phosphatase SHIP is expressed during myeloid development. Blood 1999; 93: 1922–1933
   PubMed Web of Science ®Google Scholar
• Mancini A., Niedenthal R., Joos H., Koch A., Trouliaris S., Niemann H., Tamura T. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase. Oncogene 1997; 15: 1565–1572
   PubMed Web of Science ®Google Scholar
• McArthur G. A., Rohrschneider L. R., Johnson G. R. Induced expression of c-fms in normal hemopoietic cells shows evidence for both conservation and lineage restriction of signal transduction in response to macrophage colony-stimulating factor. Blood 1994; 83: 972–981
   PubMed Web of Science ®Google Scholar
• Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood 1998; 92: 345–348
   PubMed Web of Science ®Google Scholar
• Michaelson M. D., Bieri P. L., Mehler M. F., Xu H., Arezzo J. C., Pollard J. W., Kessler J. A. CSF-1 deficiency in mice results in abnormal brain development. Development 1996; 122: 2661–2672
   PubMed Web of Science ®Google Scholar
• Milarski K. L., Saltiel A. R. Expression of catalytically inactive syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 1994; 269: 21239–21243
   PubMed Web of Science ®Google Scholar
• Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C. H., Kuriyan J., Miller W. T. Activation of the SRC-family tyrosine kinase Hck by SH3 domain displacement. Nature 1997; 385: 650–653
   PubMed Web of Science ®Google Scholar
• Mori S., Rönnstrand L., Yokote K., Engström Å., Courtneidge S. A., Claesson-Welsh L., Heldin C.-H. Identification of two juxtamembrane autophosphorylation sites in the PDGF β-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J. 1993; 12: 2257–2264
   PubMed Web of Science ®Google Scholar
• Mugita N., Kimura Y., Ogawa M., Saya H., Nakao M. Identification of a novel, tissue-specific calpain htra-3; a human homologue of the Caenorhabditis elegans sex determination gene. Biochem. Biophys. Res. Comm. 1997; 239: 845–850
   PubMed Web of Science ®Google Scholar
• Narayana N., Cox S., Xuong N.-H., Ten Eyck L. F., Taylor S. S. A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Curr. Biol. 1997; 5: 921–935
   Google Scholar
• Noguchi T., Matozaki T., Horita K., Fujioka Y., Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 1994; 14: 6674–6682
   PubMed Web of Science ®Google Scholar
• Novak U., Harpur A. G., Paradiso L., Kanagasundaram V., Joworowski A., Wilks A. F., Hamilton J. A. Colony-stimulating factor I-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in firbroblasts. Blood 1995; 86: 2948–2956
   PubMed Web of Science ®Google Scholar
• Novak U., Mui A., Miyajima A., Paradiso L. Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J. Biol. Chem. 1996a; 271: 18350–18354
   PubMed Web of Science ®Google Scholar
• Novak U., Nice E., Hamilton J. A., Paradiso L. Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. Oncogene 1996b; 13: 2607–2613
   PubMed Web of Science ®Google Scholar
• Odai H., Sasaki K., Iwamatsu A., Nakamoto T., Ueno H., Yamagata T., Mitani K., Yazaki Y., Hirai H. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl. Blood 1997; 89: 2745–2756
   PubMed Web of Science ®Google Scholar
• Pesesse X., Deleu S., De Smedt F., Drayer L., Erneux C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Comm. 1997; 239: 697–700
   PubMed Web of Science ®Google Scholar
• Piao X., Paulson R., van der Geer P., Pawson T., Bernstein A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 1996; 93: 14665–14669
   PubMed Web of Science ®Google Scholar
• Pollard J. W., Hennighausen L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc. Natl. Acad. Sc. USA 1994; 91: 9312–9316
   PubMed Web of Science ®Google Scholar
• Pullen N., Dennis P. B., Andjelkovic M., Dufner A., Kozma S. C., Hemmings B. A., Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science 1998; 279: 707–710
   PubMed Web of Science ®Google Scholar
• Qu C. K., Feng G. S. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 1998; 17: 433–440
   PubMed Web of Science ®Google Scholar
• Reedijk M., Liu X., Pawson T. Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP associated proteins with the colony-stimulating factor 1 receptor. Mol. Cell. Biol. 1990; 10: 5601–5608
   PubMed Web of Science ®Google Scholar
• Reedijk M., Liu X., van der Geer P., Letwin K., Waterfield M. D., Hunter T., Pawson T. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J. 1992; 11: 1365–1372
   PubMed Web of Science ®Google Scholar
• Rohrschneider L. R. The macrophage-colony stimulting factor (M-CSF) receptor. Guidebook to Cytokines and Their Receptors, N. A. Nicola. Oxford University Press, Oxford 1994; 168–170
   Google Scholar
• Rohrschneider L. R., Woolford J. F. Structural and functional comparison of viral and cellular? fms. Sem. Virol. 1991; 2: 385–395
   Google Scholar
• Sano S., Ohnishi H., Omori A., Hasegawa J., Kubota M. BIT, an immune antigen receptor-like molecule in the brain. FEBS 1997; 411: 327–334
   PubMed Web of Science ®Google Scholar
• Santoro M., Carlomagno F., Romano A., Bottaro D. P., Dathan N. A., Grieco M., Fusco A., Vecchio G., Matoskova B., Kraus M. H., Di Fiore P. P. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995; 267: 381–383
   PubMed Web of Science ®Google Scholar
• Sapi E., Flick M. B., Rodov S., Gilmore-Hebert M., Kelley M., Rockwell S., Kacinski B. M. Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Canc. Res. 1996; 56: 5704–5712
   PubMed Web of Science ®Google Scholar
• Sapi E., Kacinski B. M. The role of CSF-1 in normal and neoplastic breast physiology. Proc. Soc. Exp. Biol. Med. 1999; 220: 1–8
   PubMed Web of Science ®Google Scholar
• Sattler M., Salgia R., Shrikhande G., Verma S., Choi J.-L., Rohrschneider L. R., Griffin J. D. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 1997; 15: 2379–2384
   PubMed Web of Science ®Google Scholar
• Scholl S. M., Pallud C., Beuvon F., Hacene K., Stanley R., Rohrschneider L., Ting R., Pouillart P., Liderean R. CSF-1 (Colony Stimulating Factor-1) in primary breast carcinomas correlates with marked inflammatory cell infiltrates and prognosis. J. Natl. Cancer Inst. 1994; 86: 120–126
   PubMedGoogle Scholar
• Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 1997; 385: 602–609
   PubMed Web of Science ®Google Scholar
• Silvennoinen O., Schindler C., Schlessinger J., Levy D. E. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 1993; 261: 1736–1739
   PubMed Web of Science ®Google Scholar
• Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64: 693–702
   PubMed Web of Science ®Google Scholar
• Stanley E. R., Berg K. L., Einstein D. B., Lee P. S., Yeung Y. G. The biology and action of colony stimulating factor-1. Stem Cells 1994; 12: 15–24, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R. J., Reese C. B., McCormick F., Tempst P., Coadwell J., Hawkins P. T. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998; 279: 710–714
   PubMed Web of Science ®Google Scholar
• Stokoe D., Stephens L. R., Copeland T., Gaffney P. R. J., Reese C. B., Painter G. F., Holmes A. B., McCormick F., Hawkins P. T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 1997; 277: 567–570
   PubMed Web of Science ®Google Scholar
• Tang T. L., Freeman R. M. J., O'Reilly A. M., Neel B., Sokol S. Y. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus developement. Cell 1995; 80: 473–483
   PubMed Web of Science ®Google Scholar
• Tapley P., Kazlauskas A., Cooper J. A., Rohrschneider L. R. Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells. Mol. Cell. Biol. 1990; 10: 2527–2537
   Web of Science ®Google Scholar
• Timms J. F., Carlberg K., Gu H., Chen H., Kamatkar S., Nadler M. J. S., Rohrschneider L. R., Neel B. G. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 1998; 18: 3838–3850
   PubMed Web of Science ®Google Scholar
• Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 1996; 8: 205–215
   PubMed Web of Science ®Google Scholar
• Trouliaris S., Smola U., Chang J.-H., Parsons S. J., Niemann H., Tamura T. Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP. J. Virol. 1995; 69: 6010–6020
   PubMed Web of Science ®Google Scholar
• van der Geer P., Hunter T. Tyrosine 706 and 807 phosphorylation site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription. Mol. Cell. Biol. 1991; 11: 4698–4709
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B., Leevers S. J., Panayotou G., Waterfield M. D. Phosphoinositide 3-kinases: a conserved family of signal transducers. TIBS 1997; 22: 267–272
   PubMed Web of Science ®Google Scholar
• Wang Y., Yeung Y. G., Stanley E. R. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cb1 follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 1999; 72: 119–134
   PubMed Web of Science ®Google Scholar
• Wang Z., Myles G., Brandt C. S., Lioubin M. N., Rohrschneider L. R. Identification of the ligand-binding regions in the Macrophage colony-stimulating factor receptor extracellular domain. Mol. Cell. Biol. 1993; 13: 5348–5359
   PubMed Web of Science ®Google Scholar
• Wiktor-Jedrzejczak W., Urbanowska E., Aukerman S. L., Pollard J. W., Stanley E. R., Ralph P., Ansari A. A., Sell K. W., Szperl M. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp. Hematol. 1991; 19: 1049–1054
   PubMed Web of Science ®Google Scholar
• Wisniewski D., Strife A., Swendeman S., Erdjument-Bromage H., Geromanos S., Kavanaugh W. M., Tempst P., Clarkson B. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 1999; 93: 2707–2720
   PubMed Web of Science ®Google Scholar
• Xu W., Harrison S. C., Eck M. J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997; 385: 595–602
   PubMed Web of Science ®Google Scholar
• Yao R., Cooper G. M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003–2006
   PubMed Web of Science ®Google Scholar